Ipratropium bromide in children with asthma
- PMID: 6461943
- PMCID: PMC459250
- DOI: 10.1136/thx.37.1.72
Ipratropium bromide in children with asthma
Abstract
Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods. Ipratropium bromide, given in addition to their current treatment, was compared with placebo using a double-blind crossover technique. The period of treatment with ipratropium was associated with a significant reduction in symptoms during both day and night and significantly higher morning peak expiratory flow rates.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical